Advertise on podcast: BioTech Nation ... with Dr. Moira Gunn

Dr. Marc Salzberg, CEO & Chief Medical Officer of Airway Therapeutics, talks about what they are doing to help preterm babies. It may all boil down to delivering these babies a single protein as soon as they are born. 

On this week's episode of BioTech Nation, Dr. Daniel Kraft discusses the "now-near-next" approach he uses when talking about innovation in healthcare...and beyond. From biotech breakthroughs to AI "agentification", this framework can help us see the bigger picture, and envision the possibilities of where we could be headed next. 

This week on BioTech Nation, we celebrate the life of the late Dr. Phil Low, Purdue University Distinguished Professor of Chemistry and biotech entrepreneur. In this 2017 interview, he describes the development of fluorescence-guided surgery - and why it's a game-changer for cancer treatment. 

On this week's BioTech Nation...want to go to space? Well...it's never too late to follow your dreams, and Tech Nation Health Chief Correspondent Dr. Daniel Kraft joins us to talk about who could medically qualify to climb aboard and rocket into orbit. His answers may surprise you...

On this week's BioTech Nation...what could the future of American Healthcare look like? Moira speaks with Dr. Marschall Runge, University of Michigan Medical School Professor, about how Big Tech is quickly redefining the entire healthcare system. His book is, “The Great Healthcare Disruption: Big Tech, Bold Policy, and the Future of American Medicine.” 

On this week’s BioTech Nation, Moira speaks with Dr. Adam Rogers, CEO of NervGen Pharma, about a new treatment that’s showing significant trial results for patients with spinal cord injuries. While typically, patient progress is defined by the early months of recovery after the injury, some trial participants have seen increased function as much as 10 years post-trauma. 

On this week’s Biotech Nation, Moira speaks with Dr. Arun Swaminathan about an intervention for ALS that Coya Therapeutics is taking into phase two clinical trials. The goal? To stop progression of the disease in its tracks. It could even help in patients with Parkinson’s, Alzheimers, and Frontotemporal Dementia.

What if you could routinely screen for early cancer, detecting it while it's easier to treat? Tech Nation Health Chief Correspondent, Dr. Daniel Kraft discusses the latest diagnostics that could allow us to do just that. From blood tests to full-body scans, the future of cancer screening could mean finding cancer before obvious symptoms even begin...

On this week’s Biotech Nation, how doctors and hospitals are using AI, and how it could change the practice of medicine. Moira speaks with Dr. Robert Wachter about his book, “A Giant Leap: How AI is Transforming Healthcare and What That Means for Our Future”.

You may already use "Dr. ChatGPT" to answer your medical questions... but now, OpenAI has announced the rollout of ChatGPT Health and OpenAI for Healthcare. Dr. Daniel Kraft has the latest on how each platform will work, and what happens with the health data you share. 

This week on BioTech Nation, what is AI-Powered Biology? Dr. Shana Kelley, President of Bioengineering and Head of Biohub, Chicago for the Chan-Zuckerberg Initiative, discusses how AI can be used to accelerate research, and what this could mean for the future.  

This is the 2026 BioTech Nation "5": Five Companies Ready to Make a Difference. We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco. Hear all 5 interviews at https://www.biotechnation.com/jpm-2026-btn-5 On this episode of BioTech Nation...Ever wonder what makes opioids so addictive? Moira speaks with Ketan Mehta, Founder and CEO of Tris Pharma, about opioid-induced euphoria...and an opioid that's actually meant to suppress this response.  For more information about BioTech Nation and the companies featured here, visit: TechNation.com

This is the 2026 BioTech Nation "5": Five Companies Ready to Make a Difference. We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco. Hear all 5 interviews at https://www.biotechnation.com/jpm-2026-btn-5 On this episode of BioTech Nation...Moira speaks with Neil Klompas of Augurex Life Sciences, about a new diagnostic for chronic, long-term back pain that pinpoints a form of arthritis. On average, patients with this condition could go 7-10 years without a diagnosis, having to first eliminate everything else with an odyssey of tests. Now, a simple blood test could be the answer. For more information about BioTech Nation and the companies featured here, visit: TechNation.com

This is the 2026 BioTech Nation "5": Five Companies Ready to Make a Difference. We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco. Hear all 5 interviews at https://www.biotechnation.com/jpm-2026-btn-5 On this episode of BioTech Nation, Moira speaks with Dr. Barry Quart, CEO of Connect Biopharma, about a new fast-acting treatment for inflammatory conditions like Asthma, COPD, and Eczema. Often, these conditions can be managed with anti-inflammatory therapeutics like Dupixent, but even then, sudden and painful flare-ups can occur. We take a closer look at a new anti-inflammatory in late-stage development which starts working quickly, much needed when those flare-ups develop.  For more information about BioTech Nation and the companies featured here, visit: TechNation.com

This is the 2026 BioTech Nation "5": Five Companies Ready to Make a Difference. We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco. Hear all 5 interviews at https://www.biotechnation.com/jpm-2026-btn-5 On this episode of BioTech Nation...Dr. Harry Selker & Dr. Atul Deshpande of Immediate Therapeutics speak with Moira about a new treatment that could be administered to heart attack patients right away...potentially before they even arrive at the hospital. Already successfully tested in Phase 2, it’s ready to go into final pivotal trials in Ambulances and Emergency Rooms. For more information about BioTech Nation and the companies featured here, visit: TechNation.com